MAN1B1
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase
Also known as: ERMan1, ERManI, MA1B1_HUMAN, MANA-ER, MRT15
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKM7
- Gene
- MAN1B1
- Ensembl
- ENSG00000177239
- Chromosome
- 9
- Canonical length
- 699 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes an enzyme belonging to the glycosyl hydrolase 47 family. This enzyme functions in N-glycan biosynthesis, and is a class I alpha-1,2-mannosidase that specifically converts Man9GlcNAc to Man8GlcNAc isomer B. It is required for N-glycan trimming to Man5-6GlcNAc2 in the endoplasmic-reticulum-associated degradation pathway. Mutations in this gene cause autosomal-recessive intellectual disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 11. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
699 residues, UniProt reviewed canonical sequence.
>Q9UKM7|MAN1B1
1 MAACEGRRSG ALGSSQSDFL TPPVGGAPWA VATTVVMYPP PPPPPHRDFI SVTLSFGENY
61 DNSKSWRRRS CWRKWKQLSR LQRNMILFLL AFLLFCGLLF YINLADHWKA LAFRLEEEQK
121 MRPEIAGLKP ANPPVLPAPQ KADTDPENLP EISSQKTQRH IQRGPPHLQI RPPSQDLKDG
181 TQEEATKRQE APVDPRPEGD PQRTVISWRG AVIEPEQGTE LPSRRAEVPT KPPLPPARTQ
241 GTPVHLNYRQ KGVIDVFLHA WKGYRKFAWG HDELKPVSRS FSEWFGLGLT LIDALDTMWI
301 LGLRKEFEEA RKWVSKKLHF EKDVDVNLFE STIRILGGLL SAYHLSGDSL FLRKAEDFGN
361 RLMPAFRTPS KIPYSDVNIG TGVAHPPRWT SDSTVAEVTS IQLEFRELSR LTGDKKFQEA
421 VEKVTQHIHG LSGKKDGLVP MFINTHSGLF THLGVFTLGA RADSYYEYLL KQWIQGGKQE
481 TQLLEDYVEA IEGVRTHLLR HSEPSKLTFV GELAHGRFSA KMDHLVCFLP GTLALGVYHG
541 LPASHMELAQ ELMETCYQMN RQMETGLSPE IVHFNLYPQP GRRDVEVKPA DRHNLLRPET
601 VESLFYLYRV TGDRKYQDWG WEILQSFSRF TRVPSGGYSS INNVQDPQKP EPRDKMESFF
661 LGETLKYLFL LFSDDPNLLS LDAYVFNTEA HPLPIWTPALocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAN1B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- ovary: 28 nTPM
- salivary gland: 20 nTPM
- pancreas: 20 nTPM
- placenta: 19 nTPM
- fallopian tube: 19 nTPM
- blood vessel: 19 nTPM
Single-cell type
- extravillous trophoblasts: 102 nCPM
- migrating cytotrophoblasts: 66 nCPM
- cytotrophoblasts: 62 nCPM
- syncytiotrophoblasts: 50 nCPM
- decidual stromal cells: 48 nCPM
- differentiating spermatogonia: 47 nCPM
Immune cell
- non-classical monocyte: 37 nTPM
- myeloid DC: 33 nTPM
- intermediate monocyte: 30 nTPM
- total PBMC: 29 nTPM
- gdT-cell: 29 nTPM
- T-reg: 29 nTPM
Brain region
- pons: 17 nTPM
- choroid plexus: 15 nTPM
- hypothalamus: 14 nTPM
- white matter: 14 nTPM
- medulla oblongata: 13 nTPM
- midbrain: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAN1B1.
Disease | AllUniProt
Conditions MAN1B1 is implicated in, by any mechanism.
- Rafiq syndrome (RAFQS) MIM:614202
Disease | GeneticClinVar
52 pathogenic / likely-pathogenic of 646 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Rafiq syndrome
- Inborn genetic diseases
- MAN1B1-related disorder
- See cases
- MAN1B1-congenital disorder of glycosylation
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.73
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum mannose trimming
- ERAD pathway
- N-glycan processing
- oligosaccharide metabolic process
- viral protein processing
- protein alpha-1,2-demannosylation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAN1B1 as an antibody target. Whether an autoantibody or antibody against MAN1B1 could matter depends on whether native MAN1B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAN1B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAN1B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...